E Leuridan1, N Goeyvaerts, N Hens, V Hutse, P Van Damme. 1. Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, WHO Collaborating Centre for Control and Prevention of Infectious Diseases, University of Antwerp, UA-CDE-R 2.13, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium. elke.leuridan@ua.ac.be
Abstract
UNLABELLED: The duration of the presence of maternal mumps antibodies in a prospective cohort study is presented. Immunoglobulin G against mumps was portioned with a commercial ELISA test (Euroimmun® anti-mumps Virus AT ELISA, Germany) on samples from 213 mother-child pairs at seven time points between pregnancy and 12 months of age. Non-linear mixed models were used to model maternal antibody decay in infants. The model-based median time to loss of antibodies was 3.6 months. The median child-specific time to loss of antibodies in children of naturally immune women (3.8 months) and children of vaccinated women (2.4 months) differed significantly (p = 0.025). The log antibody level of the mother and the log birth weight were correlated with the duration of maternal antibodies in infants (p < 0.0001). CONCLUSION: Children of vaccinated women loose maternal mumps antibodies significantly earlier in life compared to children of naturally infected women. If early administration (<12 months) of the combined measles, mumps, and rubella vaccine is needed, maternal mumps antibodies are not expected to interfere with infant humoral vaccine responses.
UNLABELLED: The duration of the presence of maternal mumps antibodies in a prospective cohort study is presented. Immunoglobulin G against mumps was portioned with a commercial ELISA test (Euroimmun® anti-mumps Virus AT ELISA, Germany) on samples from 213 mother-child pairs at seven time points between pregnancy and 12 months of age. Non-linear mixed models were used to model maternal antibody decay in infants. The model-based median time to loss of antibodies was 3.6 months. The median child-specific time to loss of antibodies in children of naturally immune women (3.8 months) and children of vaccinated women (2.4 months) differed significantly (p = 0.025). The log antibody level of the mother and the log birth weight were correlated with the duration of maternal antibodies in infants (p < 0.0001). CONCLUSION:Children of vaccinated women loose maternal mumps antibodies significantly earlier in life compared to children of naturally infected women. If early administration (<12 months) of the combined measles, mumps, and rubella vaccine is needed, maternal mumps antibodies are not expected to interfere with infant humoral vaccine responses.
Authors: H Theeten; V Hutse; N Hens; Y Yavuz; K Hoppenbrouwers; P Beutels; R Vranckx; P Van Damme Journal: Epidemiol Infect Date: 2010-06-29 Impact factor: 2.451
Authors: I Karagiannis; A van Lier; R van Binnendijk; Helma Ruijs; H Ruijs; E Fanoy; M A E Conyn-Van Spaendonck; H de Melker; S Hahné Journal: Euro Surveill Date: 2008-06-12
Authors: M I de Moraes-Pinto; A C Almeida; G Kenj; T E Filgueiras; W Tobias; A M Santos; M M Carneiro-Sampaio; C K Farhat; P J Milligan; P M Johnson; C A Hart Journal: J Infect Dis Date: 1996-05 Impact factor: 5.226
Authors: Gustavo H Dayan; M Patricia Quinlisk; Amy A Parker; Albert E Barskey; Meghan L Harris; Jennifer M Hill Schwartz; Kae Hunt; Carol G Finley; Dennis P Leschinsky; Anne L O'Keefe; Joshua Clayton; Lon K Kightlinger; Eden G Dietle; Jeffrey Berg; Cynthia L Kenyon; Susan T Goldstein; Shannon K Stokley; Susan B Redd; Paul A Rota; Jennifer Rota; Daoling Bi; Sandra W Roush; Carolyn B Bridges; Tammy A Santibanez; Umesh Parashar; William J Bellini; Jane F Seward Journal: N Engl J Med Date: 2008-04-10 Impact factor: 91.245
Authors: Katrina Vanura; Franz Rieder; Marie-Theres Kastner; Julia Biebl; Michael Sandhofer; Trang Le; Robert Strassl; Elisabeth Puchhammer-Stöckl; Thomas Perkmann; Christoph F Steininger; Kostas Stamatopoulos; Wolfgang Graninger; Ulrich Jäger; Christoph Steininger Journal: PLoS One Date: 2013-10-23 Impact factor: 3.240